Pillstats
Labeler · US market

Lonza Biologics, Inc.

Lonza Biologics, Inc. is a US drug labeler with US FDA registrations covering 24 drug concepts (24 currently active) across 41 packages. It is currently the only active US supplier of 20 drugs. The company files with FDA under 2 name variants, merged into this profile.

Also files as: Lonza Biologics, plc

ACTIVE — US
openFDA · updated weekly
Labeler codes17504 · 67643
Active drugs24
Registrations29 active / 29
Packages41
Sole supplier of20 drugs

Portfolio24 drugs · US

Every drug concept this labeler has US registrations for, by package count.

DrugTypeNDCsPackagesStatus
Pertuzumab
liquid
other36SUPPLYING
Rituximab
liquid
other23SUPPLYING
Ocrelizumab
liquid
other23SUPPLYING
Infliximab 40.0 Mg/Ml Drug Substance
liquid
other12SUPPLYING
Burosumab
liquid
other12SUPPLYING
Asfotase Alfa
liquid
other12SUPPLYING
Tisotumab
liquid
other12SUPPLYING
Emapalumab 25 Mg/Ml
liquid
other12SUPPLYING
Efgartigimod
liquid
other12SUPPLYING
Ni-0501 6 Mg/Ml
liquid
other12SUPPLYING
Tocilizumab
liquid
other22SUPPLYING
Tafasitamab
liquid
other11SUPPLYING
Blinatumomab
liquid
other11SUPPLYING
Lisocabtagene Maraleucel Lentivirus Vector
suspension
other11SUPPLYING
Eftrenonacog Alfa
liquid
other11SUPPLYING
Efgartigimod Drug Substance
liquid
other11SUPPLYING
Isatuximab
liquid
other11SUPPLYING
Maby
liquid
other11SUPPLYING
Mepolizumab Drug Substance
liquid
other11SUPPLYING
Fremanezumab
liquid
other11SUPPLYING
Vedolizumab Iv
liquid
other11SUPPLYING
Obiltoxaximab
liquid
other11SUPPLYING
Vedolizumab Sc
liquid
other11SUPPLYING
Ofatumumab
liquid
other11SUPPLYING